PositiveID Corporation and its ExcitePCR Corporation subsidiary, announced that Lawrence Livermore National Laboratory has completed an analysis and report of the FireflyDX real-time polymerase chain reaction (PCR) pathogen detection prototype. The FireflyDX™ prototype system is designed to be a portable, fully automated, lab quality, real-time device able to process samples and detect pathogens at the point of care/point of need (POC/PON), faster and less expensively than existing devices. FireflyDX's applications include the near real-time detection of pathogenic organisms in verticle markets addressing human clinical applications, infectious diseases, and hospital acquired infections; agricultural and food screening in both domestic sectors and developing countries; and detection of biological agents associated with weapons of mass destruction. The report, which has been partially redacted due to the proprietary nature of certain content, was prepared under agreement between PositiveID and Lawrence Livermore National Laboratory.